Skip to main content
Watch Insiders
SKYE filings

Corporate insider profile

Andrew J. Schwab Filing Activity

Latest reported as Director / 10% Owner of Skye Bioscience, Inc. (SKYE).

Purchase filings
0
Reported companies
3
Net open-market value
-$3,939,656.96
Latest transaction
Sep 16, 2026

Affiliated corporations

Reported company relationships

SKYELatest reported

Skye Bioscience, Inc.

Director / 10% Owner

CAMPPrior filing

Camp4 Therapeutics Corp

Director

TRDAPrior filing

Entrada Therapeutics, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 16, 2026Skye Bioscience, Inc. (SKYE)Director / 10% OwnerSale33,892$1.91$64,734
Aug 27, 2026Camp4 Therapeutics Corp (CAMP)DirectorSale400,000$4.04$1,616,000
Aug 24, 2026Camp4 Therapeutics Corp (CAMP)DirectorSale10$4.50$45.00
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium